Degradable metal full-suture anchor system
By designing a full suture anchor system with a wall thickness of 0.1 to 0.5 mm, the suture contraction mechanism and braided structure are used to fix the bone tract, and the degradation rate is regulated by alloying elements and surface treatment, the wall in the prior art is solved. The problems of thickness and degradation cycle achieve higher bioadaptability and healing promotion effects.
Patent Information
- Application Number
- CN202411185018.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-07-08
- Filing Date
- 2024-08-27
- Publication Date
- 2024-11-12
AI Technical Summary
The wall thickness and diameter of existing degradable metal strap anchors are difficult to further reduce, resulting in increased bone trauma during implantation and prolonged degradation cycle, affecting biological adaptability.
The fully suture anchor system is designed using a biodegradable wire material. The fully suture anchor system with a wall thickness of 0.1 to 0.5mm is made by pre-bending and braiding structure combined with welding or braiding winding. The contraction mechanism of the suture is used to make the whole suture anchor with a wall thickness of 0.1 to 0.5mm. The bone tract is fixed internally and the degradation rate is regulated by alloying elements and surface coating.
The wall thickness and weight of the full suture anchors have been significantly reduced, the degradation rate has been improved, and the degradation time has been shortened to 6 to 9 months, reducing the implant quality and bioabsorption burden, and improving bioadaptation and healing promotion effect.
Smart Images

Figure CN118924365A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of medical devices, and in particular to a degradable metal full suture anchor system. Background Art
[0002] Wire anchors are one of the important tools in bone and joint surgery. Their main function is to fix soft tissues such as ligaments or tendons to bone tissue to form a strong and stable bone fixation point. In order to restore the function of the damaged part, the anchor must provide sufficient mechanical stability while reducing the negative impact on the healing of the damaged tissue, and preferably promote the healing of the damaged tissue. Wire anchors are widely used in the treatment of tendon tears, myofasciitis, ligament injuries, ankle fractures, finger swan neck deformities, etc.
[0003] Traditional anchor materials are made of medical stainless steel, medical titanium alloy, polyetheretherketone (PEEK) and medical polymer materials. Non-degradable metal materials and polyetheretherketone have corrosion resistance and mechanical stability, but because they are non-degradable, a second operation must be performed to remove the implant from the human body after the injured tissue heals, which will lead to increased medical costs and patient morbidity. Inflammation and cysts are prone to occur around medical degradable polymer anchors, and the failure load is low. Degradable metals are a solution to the above problems because of their good mechanical properties and biocompatibility, and they can be degraded to avoid secondary surgery for removal. The patent (CN 115245363 A) discloses a wire anchor made of zinc-manganese-magnesium alloy. The wire anchor is provided with a drug storage cavity and a drug release hole, which can delay the drug release rate, increase the drug penetration into bone tissue, and promote bone tissue growth.
[0004] Reducing the wall thickness of degradable metal wire anchors can reduce implant mass, shorten degradation cycle, and improve biocompatibility. The wall thickness of existing degradable metal wire anchors is limited by machining technology, and it is difficult to reduce the thickness to less than 2 mm. Therefore, innovative solutions are needed to support ultra-thin wall anchors. Summary of the invention
[0005] The technical problems solved by the present invention are as follows: in view of the urgent need to further reduce the wall thickness and diameter of the current degradable metal wire anchor to reduce bone canal trauma during implantation, reduce implantation mass, shorten the degradation cycle, and further improve biocompatibility, the present invention designs a full suture anchor system using degradable metal wires, and provides preparation, processing and assembly methods thereof. The wall thickness of the prepared degradable metal full suture anchor is 0.1-0.5 mm; the weight of a single degradable zinc alloy full-wire anchor is 0.1-0.7 g, which is approximately 10%-40% of the weight of a traditional zinc alloy wire anchor; the degradation rate of the zinc alloy full suture anchor is 0.15-0.25 mm / year, while the degradation rate of the traditional zinc alloy wire anchor is 0.05-0.07 mm / year. The zinc alloy full suture anchor can be completely degraded in 6-9 months, and the degradation time is significantly shortened compared with the traditional zinc alloy wire anchor.
[0006] A degradable metal all-suture anchor system, the all-suture anchor system comprising:
[0007] (1) Suture A and suture B, wherein the sutures have a first length of ≥15 mm;
[0008] (2) a full suture anchor that can slide in a direction parallel to the suture to be contracted, the full suture anchor having a second length in a non-contracted state, and a third length that contracts into a ball shape after the suture is pulled in a direction parallel to the suture in the bone tunnel, the third length being smaller than the second length, and the second length being smaller than the first length;
[0009] The materials of the sutures A and B, and all suture anchors are medical degradable metals, including medical degradable pure zinc and zinc alloys, and pure magnesium and magnesium alloys.
[0010] Furthermore, the full suture anchor comprises a fixed frame and a braided structure, wherein the fixed frame maintains the integrity of the braided structure, and the braided structure has two structures: a first braiding structure and a second braiding structure:
[0011] (1) The first braided structure is a long strip of braided fabric with a plurality of threading holes, which form a receiving portion, and the sutures A and B cross through the threading holes; specifically, a plurality of degradable metal wires are selected, pre-bent into a specific wavy shape, and then the wires are wound in rows to assemble into a planar braided structure with diamond-shaped holes, and finally the braided structure is assembled onto a fixed frame by welding or braiding and winding to form a full suture anchor.
[0012] (2) The second braided structure is a cylindrical braid having an inner cavity, which forms a receiving portion, and the sutures A and B pass through the inner cavity in parallel; specifically, a number of degradable metal wires are selected, pre-bent into a wavy shape with diamond-shaped through holes, and then the wires are wound in rows to assemble into a specific cylindrical braided structure, and finally the braided structure is assembled onto a fixing ring by welding or braiding and winding to form a full suture anchor.
[0013] Furthermore, the medical biodegradable zinc alloy contains at least one of the following alloying elements: 0.01-5wt% Mn, 0.01-5wt% Mg, 0.01-5wt% Sr, 0.01-5wt% Ti, 0.01-2wt% Ca, 0.01-5wt% Cu, 0.01-2wt% Li, 0.01-5wt% Fe, 0.01-5wt% Ag, 0.01-5wt% Co, 0.01-5wt% Cr, 0.01-5wt% Ce, 0.01-5wt% Ge, and 0.01-5wt% Sn.
[0014] Furthermore, the medical biodegradable magnesium alloy contains at least one of the following alloying elements: 0.01% to 1.0wt% Ca, 0.01% to 3.5wt% Zn, 0.01% to 5wt% Mn, 0.01% to 5wt% Sr, 0.01% to 5wt% Ge, 0.01% to 10wt% Gd, 0.01% to 1wt% Nd, 0.01% to 10wt% Sn, and 0.01% to 10wt% Li.
[0015] Furthermore, the elongation of the medical degradable metal in the drawn state is ≥15%, the yield strength is ≥200MPa, and the tensile strength is ≥250MPa; the degradation rate of the medical degradable zinc alloy is ≥0.15mm / year, and the degradation rate of the medical degradable magnesium alloy is ≥0.25mm / year; the degradation rate of the degradable zinc alloy full suture anchor is 0.15-0.25mm / year, and can be completely degraded in 6-9 months.
[0016] Furthermore, the diameters of the sutures A and B are 0.1 to 0.5 mm, the length of the fixed frame of the full suture anchor is 1 to 15 mm, and the width is 1 to 5 mm; the spacing between parallel sutures in the internal threading holes of the braided structure is 0.5 to 2 mm to maintain the integrity of the braided structure and the necessary anchor strength and pull-out resistance ≥ 100 N; the diameter of the ball-shaped full suture anchor in the final state is 1 to 7.5 mm.
[0017] Furthermore, a coating can be added to the surface of the full suture anchor to regulate the degradation rate. The electrolyte for preparing the coating is 0.1-1.5 g / L Na2CO3 solution, 0.1-1.5 g / L NaHCO3 solution, 0.1-1.5 g / L Na2CO3 and NaHCO3 mixed solution, 0.1-0.5 mol / L NH4F ethylene glycol solution, 0.01-5 mol / L NaOH solution, 0.1-1 mol / L H2SO4 solution, the oxidation voltage is 5-40 V, the oxidation time is 0-30 min, and the reaction temperature is 25-65 ° C; the thickness of the prepared zinc oxide coating is less than 200 μm.
[0018] The full suture anchor system of the present invention works as follows: the full suture anchor is in a non-contracted state before use. When in use, it is folded in half from the middle along the length direction and inserted into the pre-punched bone tunnel through the inserter. The folded full suture anchor is kept in the bone tunnel by the friction with the inner wall of the bone tunnel. The two ends of the sutures A and B are pulled along the length direction, which can cause the full suture anchor to produce movements such as contraction and folding to form a ball-shaped full suture anchor 4, thereby anchoring it in the bone tunnel. Afterwards, the damaged tendon can be sutured and bound by the sutures A and B, so that the damaged tendon is attached to the corresponding bone.
[0019] The differences and beneficial effects of the present invention compared with the prior art are as follows:
[0020] (1) The sutures A and B can cross and pass through the internal through holes of the full-line anchor, and the full-line anchor and the tendon tissue are inserted into the prefabricated bone channel. After being fixed, they are stretched and deformed to shrink the full-line anchor into a ball with a diameter of 1 to 7.5 mm, so that the full-line anchor is stuck in the side wall of the bone channel and fixed in the bone channel to play an anchoring role.
[0021] (2) The degradation products of the full suture anchor system of the present invention have the function of promoting tendon-bone healing and bone canal repair. Ultimately, the full suture anchor system is completely degraded and absorbed by the body, and does not require secondary surgery for removal.
[0022] (3) The full suture anchor of the present invention has good fixation effect and stability. Compared with the traditional anchor with wire, it has smaller wall thickness and weight, which reduces the burden of human body absorption or metabolic excretion of degradation products and further improves biosafety. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 A schematic diagram of the structure of a full suture anchor provided in Example 1 of the present invention;
[0024] Figure 2 A schematic diagram of the structure of another full suture anchor provided in Example 1 of the present invention;
[0025] Figure 3 This is a schematic diagram of the working example 1 of the present invention;
[0026] Figure 4 A flow chart for preparing a full suture anchor system according to Example 2 of the present invention;
[0027] Description of reference numerals:
[0028] exist Figure 1 In the figure, 1. Suture A; 2. Suture B; 3. Full suture anchor; including: 3-1 fixed frame and 3-2 braided structure.
[0029] exist Figure 2 In the figure, 1. Suture A; 2. Suture B; 3. Full suture anchor; including: 3-1 fixing ring and 3-2 braided structure. DETAILED DESCRIPTION
[0030] The embodiments of the present invention are described in detail below in conjunction with the accompanying drawings. It should be clear that the described embodiments are only part of the embodiments of the present invention, rather than all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0031] Implementation Example 1:
[0032] Refer to the attached Figure 1 To Attachment Figure 3 This embodiment provides a full suture anchor system, including sutures A and B and a full suture anchor, the sutures A and B cross and pass through the through holes of the full suture anchor; the diameter of the sutures A and B is ≤0.5mm, and a specific example is 0.3mm.
[0033] The full suture anchor is folded in half from the middle along the length direction and inserted into the bone canal through an inserter. The folded full suture anchor is maintained in the bone canal by friction with the inner wall of the bone canal, and then the sutures A and B are pulled along the length direction. The full suture anchor will produce movements such as contraction and folding to form a ball-like structure, which is embedded in the cancellous bone, thereby achieving the anchoring effect.
[0034] According to the above-mentioned mode of action, the thickness of the bone channel implanted with the full suture anchor of this embodiment is ≤1mm, the width is ≤5mm, and the damage to the bone tissue is relatively small. 2+ 、Zn 2+ , Ca3(PO4)2, etc. have the effect of promoting tendon-bone healing and bone canal repair. Finally, the full suture anchor system is completely degraded and absorbed by the body in 6 to 9 months, and no secondary surgery is required for removal. In comparison, the zinc alloy wire anchor made according to the traditional structure takes 18 to 24 months to completely degrade.
[0035] Implementation Example 2:
[0036] The composition of the degradable zinc alloy used to manufacture the full suture anchor system of this example is shown in Table 1-1. Adding Mg, Li, Cu, Ca and Fe can improve the strength of the anchor; adding Ti, Zr and Ge can improve the degradation uniformity of the anchor; adding Mg, Ca, Sr and Mn can improve the osteogenic performance of the anchor. In the alloy of the present invention, the elements Mn, Mg, Li, Ti, Cu, Ca, Sr, Fe and Ag form a submicron-scale dispersed MnZn alloy. 13 Phase, Mg2Zn 11 phase, LiZn4 phase, TiZn 16 phase, CuZn4 phase, CaZn 13 Phase, SrZn 13 Phase, FeZn 13 Phase, AgZn3 phase, these phases can significantly refine the grains, thereby improving the strength and plasticity of the degradable zinc alloy. Adding Sn and Ge elements to the Zn matrix forms a single phase, hindering dislocation movement, thereby improving the strength of the degradable zinc alloy. Adding Ce elements can refine FeZn 13 Phase, AgZn3 phase, CuZn4 phase and other second phase size, improve the strengthening effect. Adding Cu, Ag, Ca, etc. can improve the antibacterial property of degradable zinc alloy.
[0037] Table 1-1
[0038] Invention Example Degradable zinc alloy composition (mass percentage) Alloy 1 Zn-0.8Mn-0.4Mg Alloy 2 Zn-0.2Mn-0.05Mg-0.05Sr Alloy 3 Zn-1Cu-0.2Mg Alloy 4 Zn-3Mg-0.8Cu Alloy 5 Zn-3Ag-0.5Ca-0.1Sr Alloy 6 Zn-2Cu-0.5Li-0.4Mn Alloy 7 Zn-0.8Ca-0.1Ce Alloy 8 Zn-1Ag-0.1Sn
[0039] This embodiment also provides a method for preparing a full suture anchor (see attached Figure 4 The process includes six steps: casting, hot extrusion, cold forging, drawing, weaving and post-processing, as shown below:
[0040] S1: The casting comprises the following steps: preparing high-purity metal raw materials according to the alloy composition, placing the raw materials in a smelting device for smelting, the melt refining temperature is 500-750°C, and after refining and heat preservation for 5-15 minutes, pouring the melt into a mold, the mold material is graphite, steel, etc., and cooling to obtain a zinc alloy ingot; preferably, placing the raw materials in a smelting device such as a vacuum induction melting furnace.
[0041] S2: For the hot extrusion, the zinc alloy ingot is first kept warm in a box furnace at 100-300°C for 0.5-4h, and then extrusion is started at 100-300°C; the initial diameter of the extruded sample ranges from 20-40mm, the diameter after extrusion is 5-10mm, and the extrusion ratio is 4-64. After extrusion, it is cooled in air. This step can increase the tensile strength of the degradable zinc alloy from ≤100MPa in the cast state to ≥230MPa, and increase its elongation from ≤3% in the cast state to ≥15%, thereby significantly improving the processing formability of the zinc alloy. Otherwise, if the cast zinc alloy obtained in step S1 is directly subjected to cold rotary forging in step S3, crack defects or even fractures will appear on the surface of the zinc alloy.
[0042] S3: In the cold rotary forging, the zinc alloy rod with a diameter of 5 to 10 mm obtained after hot extrusion is rotary forged in one pass at room temperature to a diameter of 1 to 3 mm, and the rotary forging rate is 1 to 5 mm / s; the grain size of the obtained rotary forged zinc alloy is significantly refined compared with that of the extruded state; taking Invention Example 2 in Table 1-1 as an example, its grain size is reduced from 7 μm in the extruded state to 0.9 μm in the rotary forging state, and a fine and uniform submicron zinc grain structure is obtained, resulting in a significant improvement in the plasticity of the zinc alloy, and the room temperature elongation is increased from 25% to 50%, so that the drawing in step S4 can be carried out continuously in multiple passes at room temperature without the need for intermediate annealing;
[0043] S4: The drawing is to use a drawing machine to perform multiple drawing of the cold swaged zinc alloy wire at room temperature to obtain a zinc alloy wire with a diameter of 0.1 to 0.5 mm that meets the requirements of full suture anchor braiding; the properties of the zinc alloy drawn wire finally obtained are as follows: elongation ≥15%, yield strength ≥200 MPa, tensile strength ≥250 MPa; degradation rate ≥0.15 mm / year; as a specific example, the elongation of the inventive alloy 2 in Table 1-1 is 58%, the yield strength is 235 MPa, the tensile strength is 320 MPa, and the degradation rate in simulated body fluid (SBF) is 0.17 mm / year;
[0044] S5: the braiding, using a braiding machine to braid the drawn zinc alloy wire into a whole suture anchor system;
[0045] S6: The post-processing includes the following 5 steps:
[0046] S6-1. Degreasing: Degrease the entire suture anchor to remove surface oil stains;
[0047] S6-2. Pickling: After the degreased full suture anchor is washed with water, it is placed in a pickling activator for pickling activation treatment. The pickling activator uses water as a solvent and includes the following components calculated by concentration: 5-sulfosalicylic acid 3-15g / L; potassium fluoride 1-5g / L;
[0048] S6-3. Cleaning: Clean the whole suture anchor after acid washing by placing it in an ultrasonic cleaner with deionized water;
[0049] S6-4. Shot peening: After cleaning, the entire suture anchor is shot peened at a pressure of 0.1 to 1.5 MPa for 5 to 20 minutes;
[0050] S6-5. Sterilization: The shot-peened full suture anchor is sterilized in a desktop autoclave for 12 to 24 hours to obtain a finished full suture anchor;
[0051] In contrast, the preparation method of the traditional zinc alloy wire anchor is: casting, extrusion, machining, and post-processing; the machining uses a CNC lathe to cut the wire anchor from the extruded rod. Compared with the full suture anchor of this embodiment, there is a significant difference that the preparation steps of the traditional zinc alloy wire anchor do not include cold forging and drawing, and there is no machining in the preparation steps of the full suture anchor of this embodiment.
[0052] Implementation Example 3:
[0053] The alloy of the full suture anchor used in this embodiment is Zn-0.2Mn-0.05Mg-0.05Sr alloy (see invention alloy 2 in Table 1-1). In the embodiment of the present application, the mechanical properties, in vitro biocompatibility, degradation performance and antibacterial effect of the full suture anchor were evaluated. As a comparison, this embodiment also used invention alloy 2 to prepare a zinc alloy with a traditional structure with a full-threaded with-wire anchor. The above two anchors are referred to as full suture anchors and with-wire anchors, respectively.
[0054] The pull-out resistance test of the full-suture anchor and the wire anchor showed that the pull-out resistance of the full-suture anchor with a cluster diameter of 2 to 4 mm reached 100 to 180 N, which was equivalent to that of the wire anchor. After the pull-out resistance test, the full-suture anchor maintained its overall structural integrity and had good comprehensive mechanical properties, which could meet the implantation requirements.
[0055] According to the standard JB / T 7901-2001 "Laboratory Uniform Corrosion Full Immersion Test Method for Metal Materials", the clustered 2mm diameter full suture anchors were subjected to a 30-day in vitro degradation test in simulated body fluids, and the average degradation rate within 30 days was 0.17mm / year; similarly, the ribbon anchors were subjected to a 30-day in vitro degradation test in simulated body fluids, and the average degradation rate within 30 days was 0.042mm / year; the degradation rate of the zinc alloy full suture anchors was about 4 times that of the ribbon anchors.
[0056] According to the standard ISO10993-5:2009 "Biological Evaluation of Medical Devices Part 5: In Vitro Cytotoxicity Test", the cell compatibility test of the full suture anchor and the belt-wire anchor of this embodiment was carried out, and mouse osteoblast MC3T3-E1 cells were selected and cultured for 24 hours. The results showed that at a concentration of 100% of the leaching solution, the cell survival rate of MC3T3-E1 in the full suture anchor group reached more than 70%, while that in the belt-wire anchor group was only 30%; at a concentration of 50% of the leaching solution, the cell survival rate of the full suture anchor exceeded 100%, while that of the belt-wire anchor group was 75%, indicating that the full suture anchor has better cell compatibility than the belt-wire anchor.
[0057] According to the standard ISO 10993-12:2012 "Biological Evaluation of Medical Devices", the antibacterial properties of the full suture anchor and the belt-line anchor were tested, and Gram-negative bacteria (Escherichia coli) and Gram-positive bacteria (Staphylococcus aureus) were selected and cultured in a 37°C incubator for 24 hours. The results showed that the antibacterial rate of the full suture anchor against Escherichia coli was 95.8%, which was higher than the 94.5% of the belt-line anchor; the antibacterial rate of the full suture anchor against Staphylococcus aureus was 86.3%, which was higher than the 85% of the belt-line anchor; therefore, the antibacterial rate of the full suture anchor was better than that of the belt-line anchor, and it was more suitable for clinical application.
[0058] Implementation Example 4:
[0059] This embodiment uses the full suture anchor system prepared in Example 2 to conduct animal experiments, as follows:
[0060] (1) Twelve New Zealand white rabbits (male, 4-6 months old) weighing between 2.5kg and 3.0kg were selected. After transecting the natural shoulder ligament, a 2.5mm diameter tunnel was drilled in the scapula along the direction of the original shoulder ligament using a bone drill. The tendon graft was placed in the tunnel and stretched. The degradable zinc alloy full suture anchor system was inserted into the bone canal and the suture was stretched to shrink the full suture anchor into a ball, thereby increasing the volume of the full suture anchor, so that the full suture anchor was stuck in the side wall of the bone canal and fixed in the bone canal. The other end of the suture was fixed on the normal tendon. After surgery, the wound was thoroughly rinsed with normal saline and the wound was sutured layer by layer.
[0061] (2) The same operation was performed on the other shoulder joint using a pure titanium wire anchor as a control group.
[0062] (3) The tendon-bone tissue healing of New Zealand white rabbits in the experimental group and the control group and the biocompatibility of the anchor and bone tissue were observed. The experimental results showed that shoulder ligament reconstruction surgery only affected the activities of New Zealand white rabbits 2 days after surgery, and had no significant effect on their diet. Most New Zealand white rabbits could stand and move on the 3rd day after surgery and resume normal diet and activities. Compared with pure titanium band anchors, biodegradable zinc alloy full suture anchors significantly accelerated the formation of new bone. At the same time, the calcium-phosphorus products generated promoted bone healing and new bone formation. Local tendon calcification occurred during the healing process, which increased the uniformity of tendon-bone mechanical properties to a certain extent, showing better tendon-bone healing and biocompatibility.
Claims
1. A degradable metal suture anchor system, characterized in that: The full suture anchor system comprises: (1) Suture A and suture B, wherein the sutures have a first length of ≥15 mm; (2) a full suture anchor that can slide in a direction parallel to the suture to be contracted, the full suture anchor having a second length in a non-contracted state, and a third length that contracts into a ball shape after the suture is pulled in a direction parallel to the suture in the bone tunnel, the third length being smaller than the second length, and the second length being smaller than the first length; The full suture anchor is in a non-contracted state before use. When in use, it is folded in half from the middle along the length direction and inserted into the pre-punched bone tunnel through the inserter. The folded full suture anchor is kept in the bone tunnel by the friction with the inner wall of the bone tunnel. The two ends of the sutures A and B are pulled along the length direction, which can cause the full suture anchor to produce movements such as contraction and folding to form a cluster of full suture anchors, which are anchored in the bone tunnel; then the tendons are sutured and bound by the sutures A and B, so that the tendons are attached to the corresponding bones; compared with the existing cylindrical bone tunnels, according to the shape of the anchor with wires of the present invention, a flat bone tunnel can be used in the actual use process, and the thickness of the bone tunnel is ≤1mm and the width is ≥5mm, which causes less damage to the bone tissue; The materials of the sutures A and B, and all suture anchors are medical degradable metals, including medical degradable pure zinc and zinc alloys, and pure magnesium and magnesium alloys.
2. The degradable metal suture anchor system according to claim 1, characterized in that: The full suture anchor comprises a fixed frame and a braided structure, wherein the fixed frame maintains the integrity of the braided structure, and the braided structure has two structures: a first braided structure and a second braided structure: (1) The first braided structure is a long strip of braided fabric with a plurality of threading holes, which form a receiving portion, and the sutures A and B cross through the threading holes; specifically, a plurality of degradable metal wires are selected, pre-bent into a specific wave shape, and then the wires are wound in rows to assemble into a planar braided structure with diamond-shaped holes, and finally the braided structure is assembled onto a fixed frame by welding or braiding and winding to form a full suture anchor; (2) The second braided structure is a cylindrical braid having an inner cavity, which forms a receiving portion, and the sutures A and B pass through the inner cavity in parallel; specifically, a number of degradable metal wires are selected, pre-bent into a wavy shape with diamond-shaped through holes, and then the wires are wound in rows to assemble into a specific cylindrical braided structure, and finally the braided structure is assembled onto a fixing ring by welding or braiding and winding to form a full suture anchor.
3. The degradable metal suture anchor system according to claim 1, characterized in that: The medical degradable zinc alloy contains at least one of the following alloying elements: 0.01-5wt% Mn, 0.01-5wt% Mg, 0.01-5wt% Sr, 0.01-5wt% Ti, 0.01-2wt% Ca, 0.01-5wt% Cu, 0.01-2wt% Li, 0.01-5wt% Fe, 0.01-5wt% Ag, 0.01-5wt% Co, 0.01-5wt% Cr, 0.01-5wt% Ce, 0.01-5wt% Ge, and 0.01-5wt% Sn.
4. The degradable metal suture anchor system according to claim 1, characterized in that: The medical biodegradable magnesium alloy contains at least one of the following alloying elements: 0.01% to 1.0wt% Ca, 0.01% to 3.5wt% Zn, 0.01% to 5wt% Mn, 0.01% to 5wt% Sr, 0.01% to 5wt% Ge, 0.01% to 10wt% Gd, 0.01% to 1wt% Nd, 0.01% to 10wt% Sn, and 0.01% to 10wt% Li.
5. The degradable metal suture anchor system according to claim 1, characterized in that: The elongation of the medical degradable metal in the drawn state is ≥15%, the yield strength is ≥200MPa, and the tensile strength is ≥250MPa; the degradation rate of the medical degradable zinc alloy is ≥0.15mm / year, and the degradation rate of the medical degradable magnesium alloy is ≥0.25mm / year; the degradation rate of the degradable zinc alloy full suture anchor is 0.15-0.25mm / year, and it can be completely degraded in 6-9 months.
6. The full suture anchor system according to claim 1, characterized in that The diameters of the sutures A and B are 0.1 to 0.5 mm, the length of the fixed frame of the full suture anchor is 1 to 15 mm, and the width is 1 to 5 mm; the spacing between the parallel sutures of the internal threading holes of the braided structure is 0.5 to 2 mm to maintain the integrity of the braided structure and the necessary anchor strength and pull-out resistance ≥ 100N; the diameter of the final ball-shaped full suture anchor is 1 to 7.5 mm.
7. The degradable metal suture anchor system according to claim 1, characterized in that: The surface of the full suture anchor can be coated to regulate the degradation rate. The electrolyte for preparing the coating is 0.1-1.5 g / L Na2CO3 solution, 0.1-1.5 g / L NaHCO3 solution, 0.1-1.5 g / L Na2CO3 and NaHCO3 mixed solution, 0.1-0.5 mol / L NH4F ethylene glycol solution, 0.01-5 mol / L NaOH solution, 0.1-1 mol / L H2SO4 solution, the oxidation voltage is 5-40 V, the oxidation time is 0-30 min, and the reaction temperature is 25-65° C. The thickness of the prepared zinc oxide coating is less than 200 μm.
Citation Information
Patent Citations
Preparation method of high-strength and high-conductivity aluminum oxide dispersion-strengthened copper-based composite
CN105483419A
Full-suture anchor nail
CN109394284A
Preparation method of aluminum alloy wire for metal 3D printing
CN110273076A
Zn-Ga series alloy as well as preparation method and application thereof
CN111676390A
Full-suture anchor and anchor traction forming set
CN112754559A
Cited By
Full-suture anchor system woven with metal wires
CN120959821A
